Latest Market Challenges News

Page 1 of 69
Prestal Holdings plans to sell its core Hampers with Bite business to Gourmet Brands for up to $1 million, pending shareholder approval. The sale aims to free capital for new acquisitions but places pressure on Prestal to meet ASX compliance within six months.
Victor Sage
Victor Sage
15 May 2026
FleetPartners Group Limited reported a 7.3% rise in half-year profit to $37.05 million, driven by lease portfolio growth and the integration of Remunerator. The company declared an 11.9 cent fully franked interim dividend and confirmed a positive outlook for FY26.
Claire Turing
Claire Turing
7 May 2026
Helix Resources pushes back against Canex Metals' challenge to its Gold Basin joint venture, affirming compliance with agreements and regulatory standards despite ongoing takeover tensions.
Maxwell Dee
Maxwell Dee
6 May 2026
Nine Entertainment’s acquisition of QMS Media and sale of Nine Radio mark a strategic pivot, with strong Q3 digital and subscription revenue growth cushioning a cautious Q4 advertising environment.
Victor Sage
Victor Sage
5 May 2026
Holista Colltech has partnered with Swang Chai Chuan to develop a nano-collagen production facility in Western Australia, marking a major step in commercialising its collagen technology with a $1.6 million initial investment.
Victor Sage
Victor Sage
5 May 2026
Synlait Milk has obtained waivers from its syndicated banks on key financial covenants for the quarter ending April 2026, reflecting ongoing operational and market challenges.
Victor Sage
Victor Sage
5 May 2026
Kinatico has moved from losses to profitability while growing its SaaS revenue and increasing mobile app and admin portal usage, signaling operational momentum.
Sophie Babbage
Sophie Babbage
4 May 2026
Little Green Pharma (ASX:LGP) posted record quarterly and annual revenues driven by a surge in European sales, improved cashflow, and reduced debt. The company is on track to complete its merger with Cannatrek by June 1, 2026, while benefiting from the US rescheduling of medicinal cannabis to Schedule III.
Ada Torres
Ada Torres
30 Apr 2026
OncoSil Medical reported a 60% year-on-year increase in dose sales in Q3 FY26, boosted by expanding treatment centres and advancing clinical trials, while cost-cutting and a new manufacturing facility aim to underpin growth.
Ada Torres
Ada Torres
28 Apr 2026
Beach Energy’s Q3 FY26 output rose 7% quarter-on-quarter, led by a 174% surge in Perth Basin production following Waitsia Gas Plant compressor commissioning. The company also secured new Queensland acreage and greenlit the Moomba Central Optimisation project, though weather disruptions trimmed Cooper Basin output and prompted a production guidance cut.
Maxwell Dee
Maxwell Dee
28 Apr 2026
American Tungsten & Antimony (ASX: AT4) has set up a Level 1 ADR program with Deutsche Bank, paving the way for its planned Nasdaq listing in Q2 2026 and opening U.S. dollar trading access for American investors.
Maxwell Dee
Maxwell Dee
28 Apr 2026
HITIQ Limited's March quarter saw a remarkable 223% jump in sales to $294k, driven by the nationwide rollout of its PROTEQT™ concussion management system and initial international sales. The company bolstered its governance and advisory ranks while managing funding to support its commercial push.
Victor Sage
Victor Sage
27 Apr 2026